Qingfeng Lin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
- Cancer, Lipids, and Metabolism 1
-
- RNA modifications and cancer 4
- RNA Research and Splicing 2
- Co-authors
- Dong Shen (10 shared papers)Weidong Mao (7 shared papers)Feng Lin (2 shared papers)Qiong Wang (1 shared paper)Katrien Wijndaele (1 shared paper)Tao Liu (1 shared paper)Ulf Ekelund (1 shared paper)Xiangdong Lu (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Frontiers in Oncology (1 paper)Advanced Science (1 paper)Experimental Cell Research (1 paper)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)
- Partner nations
- ChinaNorwayUnited Kingdom
In The Last Decade
Qingfeng Lin
20 papers receiving 383 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 187
- Molecular Biology 169
- Physiology 58
- Oncology 53
- Pathology and Forensic Medicine 20
Countries citing papers authored by Qingfeng Lin
This map shows the geographic impact of Qingfeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Lin more than expected).
Fields of papers citing papers by Qingfeng Lin
This network shows the impact of papers produced by Qingfeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Lin. The network helps show where Qingfeng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingfeng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 105 | |
| 2 | 2017 | 85 | |
| 3 | 2011 | 66 | |
| 4 | 2009 | 23 | |
| 5 | 2016 | 22 | |
| 6 | 2015 | 18 | |
| 7 | 2025 | 13 | |
| 8 | 2016 | 12 | |
| 9 | 2013 | 9 | |
| 10 | 2018 | 8 | |
| 11 | 2019 | 7 | |
| 12 | 2017 | 4 | |
| 13 | 2021 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2024 | 2 | |
| 16 | 2013 | 2 | |
| 17 | [Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by adefovir in a patient with chronic hepatitis B]. | 2014 | 2 |
| 18 | 2022 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2009 | 1 |
About Qingfeng Lin
Qingfeng Lin is a scholar working on Cancer Research, Molecular Biology, Pathology and Forensic Medicine, Oncology and Immunology, having authored 20 papers that have together received 388 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), RNA Research and Splicing (2 papers), MicroRNA in disease regulation (2 papers), Biomedical Research and Pathophysiology (1 paper), Ferroptosis and cancer prognosis (1 paper), Galectins and Cancer Biology (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (187 citations), Molecular Biology (169 citations), Physiology (58 citations), Oncology (53 citations) and Pathology and Forensic Medicine (20 citations). Qingfeng Lin has collaborated with scholars based in China, Norway and United Kingdom. Frequent co-authors include Dong Shen, Weidong Mao, Feng Lin, Qiong Wang, Katrien Wijndaele, Tao Liu, Ulf Ekelund, Xiangdong Lu, Shaoping Liu and Zhili Liu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Frontiers in Oncology, Advanced Science, Experimental Cell Research and Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.